Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "author" (Marija Us-Krašovec) .

81 - 90 / 279
First pagePrevious page567891011121314Next pageLast page
81.
Dnevnik zdravljenja z zdravilom regorafenib
Janja Ocvirk, Martina Reberšek, Neva Volk, Tanja Mesti, Marko Boc, Marija Ignjatović, Nežka Hribernik, 2022, dictionary, encyclopaedia, lexicon, manual, atlas, map

Keywords: kemoterapija, rak debelega črevesa in danke, gastrointestinalni tumorji
Published in DiRROS: 14.07.2022; Views: 747; Downloads: 197
.pdf Full text (2,48 MB)

82.
Informacije o napadu podlubnikov v letu 2021
Marija Kolšek, 2022, popular article

Keywords: podlubniki, izbruh, letno poročilo, Slovenija
Published in DiRROS: 12.07.2022; Views: 575; Downloads: 158
.pdf Full text (87,02 KB)

83.
Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination
Urška Janžič, Urška Bidovec, Katja Mohorčič, Loredana Mrak, Nina Fokter Dovnik, Marija Ivanović, Maja Ravnik, Marina Čakš, Erik Škof, Jerneja Debeljak, Peter Korošec, Matija Rijavec, 2022, original scientific article

Abstract: Background: SARS-CoV-2 vaccination in cancer patients is crucial to prevent severe COVID-19 disease course. Methods: This study assessed immunogenicity of cancer patients on active treatment receiving mRNA-based SARS-CoV-2 vaccine by detection of anti-SARS-CoV-2 S1 IgG antibodies in serum, before, after the first and second doses and 3 months after a complete primary course of vaccination. Results were compared with healthy controls. Results: Of 112 patients, the seroconversion rate was 96%. A significant reduction in antibody levels was observed 3 months after vaccination in patients receiving immune checkpoint inhibitors versus control participants (p < 0.001). Adverse events were mostly mild. Conclusion: Immunogenicity after mRNA-based vaccine in cancer patients is adequate but influenced by the type of anticancer therapy. Antibody levels decline after 3 months, and thus a third vaccination is warranted.
Keywords: onkološko zdravljenje, imunogenost, osnovno cepljenje mRNA, čvrsti tumorji, anticancer treatment, immunogenicity, mRNA-based vaccination, solid cancer
Published in DiRROS: 24.06.2022; Views: 771; Downloads: 317
.pdf Full text (2,03 MB)

84.
85.
Odpornost glioblastoma na radioterapijo : vpliv rakavih matičnih celic in mikroo[ko]lja tumorja
Barbara Breznik, Bernarda Majc, Anamarija Habič, Urška Ušeničnik, Andrej Porčnik, Roman Bošnjak, Jernej Mlakar, Marija Skoblar Vidmar, Tanja Jesenko, Maja Čemažar, Tamara Lah Turnšek, Metka Novak, 2022, published scientific conference contribution (invited lecture)

Abstract: Glioblastom je najpogostejši možganski tumor pri odraslih z zelo slabo prognozo preživetja bolnikov. Ta je posledica odpornosti glioblastoma na standardno zdravljenje, ki vključuje radioterapijo in kemoterapijo. Z namenom načrtovanja učinkovitejših pristopov zdravljenja preučujemo biološke mehanizme odpornosti glioblastoma na radioterapijo s poudarkom na mikrookolju tumorja in rakavih matičnih celicah. V predkliničnih raziskavah uporabljamo napredne in personalizirane celične modele, ki posnemajo mikrookolje tumorja v bolnikih in z večjo natančnostjo napovedo odziv bolnika na zdravljenje. Hkrati so takšni modeli pomembni za testiranje novih pristopov za zdravljenje kot je imunoterapija.
Keywords: glioblastom, mikrookolje, organoidi, možganski rak, možganski tumor, onkologija
Published in DiRROS: 16.06.2022; Views: 567; Downloads: 187
.pdf Full text (89,78 KB)

86.
Stereotaktična radiokirurgija možganskih tumorjev
Marija Skoblar Vidmar, 2020, published professional conference contribution

Keywords: stereotaktično obsevanje, radiokirurgija, možganski tumorji
Published in DiRROS: 13.04.2022; Views: 853; Downloads: 254
.pdf Full text (560,81 KB)

87.
Melanom v perinatalnem obdobju – prikaz primera : Elektronski vir
Ana Erman, Marija Ignjatović, 2022, published scientific conference contribution

Keywords: melanom, rak kože, kemoterapija
Published in DiRROS: 11.04.2022; Views: 445; Downloads: 163
.pdf Full text (289,97 KB)

88.
Melanom v nosečnosti : Elektronski vir
Marija Ignjatović, 2022, published scientific conference contribution

Keywords: melanom, rak kože, nosečnost
Published in DiRROS: 11.04.2022; Views: 526; Downloads: 148
.pdf Full text (385,21 KB)

89.
Biological nanopores : engineering on demand
Ana Crnković, Marija Srnko, Gregor Anderluh, 2021, review article

Keywords: nanopores, pore-forming toxins, sensing, aptamers, oligomerization
Published in DiRROS: 06.04.2022; Views: 632; Downloads: 380
.pdf Full text (3,29 MB)
This document has many files! More...

90.
Search done in 0.32 sec.
Back to top